These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10900540)

  • 21. DEVELOPMENT AND EVALUATION OF IVABRADINE HCI-LOADED POLYMERIC MICROSPHERES PREPARED WITH EUDRAGIT L100-55 (METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER) AND ETHYL CELLULOSE FOR CONTROLLED DRUG RELEASE.
    Majeed A; Ranjha NM; Hanif M; Abbas G; Khan MA
    Acta Pol Pharm; 2017 Mar; 74(2):565-578. PubMed ID: 29624261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel combination of anionic and cationic polymethacrylate polymers for sustained release tablet preparation.
    Obeidat WM; Abu Znait AH; Sallam AS
    Drug Dev Ind Pharm; 2008 Jun; 34(6):650-60. PubMed ID: 18568916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formulation and evaluation of a pulsatile drug delivery system using time- and pH-dependant polymers.
    Kadam VD; Gattani SG
    Pharm Dev Technol; 2010; 15(1):57-63. PubMed ID: 19552544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation of controlled-release baclofen matrix tablets. II. Influence of some hydrophobic excipients on the release rate and in vitro evaluation.
    Abdelkader H; Youssef Abdalla O; Salem H
    AAPS PharmSciTech; 2008; 9(2):675-83. PubMed ID: 18500558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
    Sauer D; McGinity J
    Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of Eudragit RS-PO and Ethocel 100 matrices for the controlled release of lobenzarit disodium.
    Boza A; Caraballo I; Alvarez-Fuentes J; Rabasco AM
    Drug Dev Ind Pharm; 1999 Feb; 25(2):229-33. PubMed ID: 10065357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering polymer blend microparticles: an investigation into the influence of polymer blend distribution and interaction.
    Alhnan MA; Basit AW
    Eur J Pharm Sci; 2011 Jan; 42(1-2):30-6. PubMed ID: 20950685
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical characterization and dissolution properties of ibuprofen: Eudragit coprecipitates.
    Kislalioglu MS; Khan MA; Blount C; Goettsch RW; Bolton S
    J Pharm Sci; 1991 Aug; 80(8):799-804. PubMed ID: 1791544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Modern polymers in matrix tablets technology].
    Zimmer Ł; Kasperek R; Poleszak E
    Polim Med; 2014; 44(3):189-96. PubMed ID: 25739125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of drug release by utilizing pH-independent matrix system comprising water soluble drug verapamil hydrochloride.
    Baviskar D; Sharma R; Jain D
    Pak J Pharm Sci; 2013 Jan; 26(1):137-44. PubMed ID: 23261739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
    Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
    Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.
    Takka S; Rajbhandari S; Sakr A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):75-82. PubMed ID: 11438426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved drug delivery to the lower intestinal tract with tablets compression-coated with enteric/nonenteric polymer powder blends.
    Rujivipat S; Bodmeier R
    Eur J Pharm Biopharm; 2010 Nov; 76(3):486-92. PubMed ID: 20868750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Compression of pellets coated with various aqueous polymer dispersions.
    Dashevsky A; Kolter K; Bodmeier R
    Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peroral sustained-release film-coated pellets as a means to overcome physicochemical and biological drug-related problems. I. In vitro development and evaluation.
    Amighi K; Timmermans J; Puigdevall J; Baltes E; Moës AJ
    Drug Dev Ind Pharm; 1998 Jun; 24(6):509-15. PubMed ID: 9876616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
    Jain V; Singh R
    Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and release mechanism of diltiazem HCl prolonged release matrix tablets.
    Boyapally H; Nukala RK; Douroumis D
    Drug Deliv; 2009 Feb; 16(2):67-74. PubMed ID: 19267297
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of Once Daily Controlled-release Ibuprofen Matrix Tablets Prepared using Eudragit
    Obeidat WM; Al-Natour MA
    Curr Drug Deliv; 2022; 19(1):74-85. PubMed ID: 34176461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.